Cannabidiol, or CBD, is a compound found in the cannabis sativa plant that has been gaining popularity due to its potential health benefits. It is known to have calming effects on the brain and can help support the hippocampus, an area of the brain important for healthy emotions and memory. Studies have shown that CBD can reduce social anxiety in a way comparable to ipsapirone and diazepam (valium). It is also said to alleviate anxiety, depression, post-traumatic stress disorder, and promote sleep.
When consumed, CBD can make people feel happy, relaxed, talkative, or more likely to laugh than usual. Colors and music may appear brighter and sharper. These pleasant effects are known as a “high”. However, it is important to note that CBD is not psychoactive like THC, so users will not experience the same level of euphoria or midnight pizza cravings.
In order to ensure safety and quality, CBD content must be subject to stricter regulations with laboratory control to determine and guarantee a particular dose or content of CBD and exclude a THC content greater than 0.3% allowed by law. Despite this, there is still a risk of increased consumption of CBD due to decriminalization of marijuana and its products, which could lead to health problems, violence, crime, and lethality. Self-medication with CBD or other supplements can also cause treatment delays that make symptoms worse. It is important to be aware of false claims made by some CBD manufacturers that it can cure cancer or COVID-19. A small experiment published in the journal Neuropsychopharmacology found that CBD seemed to reduce nervousness and cognitive decline in patients with social anxiety through a simulated task of speaking in public.
CBDMD has developed a range of products from topicals to tinctures and gummies that come in different concentrations and sizes for various needs. The group has also treated a sample of gingival tissue with CBD and observed the change in mesenchymal stem cells, which could be beneficial in treating Alzheimer's Disease (AD). The treatment of opioid use disorder (OUD) with CBD carries a special risk since the amount consumed is not dosed in a controlled manner. Outside the U.
S., the prescription drug Sativex, which uses CBD as an active ingredient, is approved for muscle spasticity associated with multiple sclerosis and for pain caused by cancer. However, it should not be considered a dietary supplement since it contains pharmacologically active ingredients. A study conducted with adults who had symptoms of anxiety and lack of sleep found that 65% experienced improvements in sleep quality scores after one month of taking an average of 25 mg of CBD per day. This highlights the importance of finding the right dosage for each individual.